Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,138 | 126 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $323.56 | 18 | $0 (2020) |
| Lilly USA, LLC | $277.54 | 15 | $0 (2020) |
| Novo Nordisk Inc | $240.57 | 13 | $0 (2023) |
| GlaxoSmithKline, LLC. | $223.65 | 14 | $0 (2023) |
| Amgen Inc. | $145.16 | 8 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $123.47 | 9 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $116.58 | 7 | $0 (2019) |
| Astellas Pharma US Inc | $106.49 | 5 | $0 (2020) |
| AbbVie Inc. | $91.65 | 5 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $90.32 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $36.84 | 2 | Novo Nordisk Inc ($18.84) |
| 2022 | $29.78 | 2 | GlaxoSmithKline, LLC. ($29.78) |
| 2021 | $79.97 | 4 | Biogen, Inc. ($42.17) |
| 2020 | $232.59 | 12 | Lilly USA, LLC ($130.13) |
| 2019 | $531.22 | 33 | Amgen Inc. ($90.48) |
| 2018 | $754.91 | 44 | PFIZER INC. ($217.58) |
| 2017 | $472.90 | 29 | Novo Nordisk Inc ($115.08) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, FLUARIX QUADRIVALENT | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: RESPIRATORY | ||||||
| 02/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Diabetes | ||||||
| 08/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: VACCINES | ||||||
| 08/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2021 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $24.30 | General |
| 04/29/2021 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $17.87 | General |
| 02/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: Diabetes | ||||||
| 03/03/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/20/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $74.33 | General |
| 02/20/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 02/20/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $6.69 | General |
| 02/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/18/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: VACCINES | ||||||
| 02/11/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
| 02/04/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 01/28/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: UROLOGY | ||||||
| 01/24/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Diabetes | ||||||
| 01/07/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes | ||||||
| 11/27/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Diabetes | ||||||
| 11/05/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: UROLOGY | ||||||
| 10/30/2019 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 139 | 382 | $83,182 | $28,550 |
| 2022 | 2 | 72 | 321 | $68,121 | $20,440 |
| 2021 | 4 | 101 | 337 | $70,111 | $23,312 |
| 2020 | 2 | 70 | 230 | $47,936 | $14,379 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 66 | 285 | $64,125 | $22,604 | 35.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 25 | 26 | $8,502 | $2,733 | 32.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 27 | 45 | $7,695 | $2,484 | 32.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 21 | 26 | $2,860 | $729.10 | 25.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 39 | 245 | $55,125 | $16,227 | 29.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 33 | 76 | $12,996 | $4,213 | 32.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 43 | 240 | $54,000 | $17,502 | 32.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 35 | 65 | $9,007 | $3,459 | 38.4% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2021 | 12 | 16 | $5,344 | $1,773 | 33.2% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 11 | 16 | $1,760 | $577.44 | 32.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 41 | 177 | $39,825 | $12,043 | 30.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 29 | 53 | $8,111 | $2,336 | 28.8% |
About Dr. Eric Lewis, M.D
Dr. Eric Lewis, M.D is a Family Medicine healthcare provider based in Wolfeboro, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033171137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Lewis, M.D has received a total of $2,138 in payments from pharmaceutical and medical device companies, with $36.84 received in 2023. These payments were reported across 126 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,138).
As a Medicare-enrolled provider, Lewis has provided services to 382 Medicare beneficiaries, totaling 1,270 services with total Medicare billing of $86,682. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Wolfeboro, NH
- Active Since 04/04/2006
- Last Updated 05/11/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1033171137
Products in Payments
- ELIQUIS (Drug) $154.70
- CHANTIX (Drug) $140.20
- TRULICITY (Drug) $96.74
- ENTRESTO (Drug) $90.32
- Tresiba (Drug) $90.16
- Ozempic (Drug) $75.42
- JARDIANCE (Drug) $73.17
- Prolia (Biological) $66.98
- MYRBETRIQ (Drug) $60.51
- SHINGRIX (Biological) $57.05
- EVENITY (Biological) $56.73
- Victoza (Drug) $56.15
- Creon (Drug) $53.85
- ADVAIR (Drug) $53.58
- JANUVIA (Drug) $46.30
- FARXIGA (Drug) $39.71
- ROTATEQ (Biological) $38.28
- UBRELVY (Drug) $37.80
- FLUZONE HIGH-DOSE (Drug) $35.76
- TRELEGY ELLIPTA (Drug) $35.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wolfeboro
Dr. Paul Demasi, D.o, D.O
Family Medicine — Payments: $1,612
Jamison Costello, D.o, D.O
Family Medicine — Payments: $1,215
Dr. Robert Mathes, Md, MD
Family Medicine — Payments: $42.14
Christina Anderson, M.d, M.D
Family Medicine
Hasan Duymazlar, D.o, D.O
Family Medicine
Dr. Jim Copenhaver, M.d, M.D
Family Medicine